The patient’s perspective on the burden of psoriasis: findings based on the ROCQ, an online survey
European Journal of Dermatology · 2024
DOI: 10.1684/ejd.2024.4606 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Dermatology, 2024. Verfasst von Nathalie Quiles-Tsimaratos und 6 weiteren Autor:innen. Beteiligte Einrichtung: Service de dermatologie, Hôpital Saint Joseph, Marseille, France. Hauptthemen laut MEDLINE: Quality of Life, Psoriasis. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Psoriasis is a common chronic skin disease, with well-characterised impact on quality-of life, however, no information is available on the lifetime impact of psoriasis on patients' lives. This descriptive cross-sectional web-based survey of patients with psoriasis, recruited from an online patient community, was conducted in France in 2021. Established questionnaires (Major Life-Changing Decision Profile-MLCDP, Dermatology Life Quality Index-DLQI, Hospital Anxiety and Depression Scale [HADS]), CAGE and BRIEF-COPE) were administered together with specially created questions. In total, 301 adult patients (mean age: 46.9 years; 56% women; mean disease duration: 20.3 years) participated in the study. The MLCDP showed that a mean of 9.4 life-changing decision items were affected; the most frequently cited domains being social life (n=258; 85.7%) and physical activity (n=226; 75.1%). In addition, 183 participants (60.7%) declared at least moderate impact of their psoriasis on their quality of life (score ≥6), with a median DLQI score of 7 [IQR: 3-13]. Impact on activities of daily living, such as social life, physical activities and marital relationships, was reported by over 50% of participants. Moreover, 107 (35.5%) declared being satisfied and 66 (21.9%) very satisfied with care. Over 50% of participants reported stigma related to being considered to have a contagious disease (n=182) or being unhygienic (n=163) and undesirable (n=167). Finally, 104 participants (34.6%) presented with clinically relevant anxiety and 32 (10.6%) clinically relevant depression (score ≥11) based on the HADS. Psoriasis carries a high psychological burden and has a strong long-term impact on social functioning.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Service de dermatologie, Hôpital Saint Joseph, Marseille, France.
- UCB Pharma, Colombes, France.
- Carenity, 1 rue de Stockholm, Paris, France.
- Service de dermatologie, Hôpital Édouard Herriot, Université de Lyon, France.
Zitieren
APA
Quiles-Tsimaratos, N., Gherardi, A., Crochard, A., Hueber, M., Pain, E., Vives, A., & Villani, A. P. (2024). The patient’s perspective on the burden of psoriasis: findings based on the ROCQ, an online survey. European Journal of Dermatology. https://doi.org/10.1684/ejd.2024.4606
Vancouver
Quiles-Tsimaratos N, Gherardi A, Crochard A, Hueber M, Pain E, Vives A, et al. The patient’s perspective on the burden of psoriasis: findings based on the ROCQ, an online survey. European Journal of Dermatology. 2024. doi:10.1684/ejd.2024.4606
BibTeX
@article{QuilesTsimaratos2024,
author = {Quiles-Tsimaratos, Nathalie and Gherardi, Alexandre and Crochard, Anne and Hueber, Mélanie and Pain, Emilie and Vives, Alizé and Villani, Axel P},
title = {The patient’s perspective on the burden of psoriasis: findings based on the ROCQ, an online survey},
journal = {European Journal of Dermatology},
year = {2024},
doi = {10.1684/ejd.2024.4606}
}
EUVIMED